Zydus Lifesciences (India) and Formycon AG (Germany) have entered into an exclusive strategic partnership to license and supply FYB206, a... Read more
Category: Uncategorized
Novartis and UK Biotech Relation Announce R&D Collaboration
Novartis, the major pharmaceutical corporation, has signed a multi-program research and development partnership agreement with Relation Therapeutics, an AI-driven biotech... Read more
Moderna Partners with Nanexa to Extend Injectable Drug Efficacy
Moderna, the mRNA specialist, has entered a licensing agreement with Nanexa, a Swedish biotech company, to incorporate tailored release profiles... Read more
Pfizer Continues Global Restructuring, Hundreds of Swiss Employees Affected by Layoffs
Pharmaceutical giant Pfizer is expanding its global cost-cutting agenda, with reports indicating that hundreds of employees in Switzerland are set... Read more
Geron Pharmaceutical Corporation Implements Second Round of Workforce Reduction
Geron Corporation, the pharmaceutical company based in Foster City, California, has disclosed a substantial restructuring plan that will involve laying... Read more
State-of-the-Art Medical Facility Set to Launch in Ninh Binh
The second facility of the Vietnam - Germany Friendship Hospital, located in Ninh Binh, is preparing to commence operations starting... Read more
Pharmaceutical Firm Introduces Dual-Action Therapy for Metabolic Conditions
Cipla Limited has unveiled a new medication, known as Yurpeak, which contains the active pharmaceutical ingredient tirzepatide. This injectable treatment... Read more
European Pharma Giants Sanofi and GSK Enter Preclinical Collaboration Deals
Rival European pharmaceutical companies Sanofi and GSK have both forged new partnership agreements aimed at strengthening their respective preclinical research... Read more
Novartis Reports Positive Phase III Trial Data for Ianalumab in Immune Thrombocytopenia
Novartis has announced favorable outcomes from the Phase III clinical trial VAYHIT2, which assessed the efficacy of ianalumab combined with... Read more









